Sanofi India Ltd

Sanofi India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi India Ltd

₹ 8,279 1.54%
26 Apr 1:12 p.m.
sanofiindialtd.com BSE: 500674 NSE : SANOFI
About

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.

Key Points

India - Branded generics (79% of CY20 revenues):[1] Top-7 brands contribute ~70% of domestic sales and are growing at high single digits.[2]

Website BSE NSE
  • Market Cap ₹ 19,067 Cr.
  • Current Price ₹ 8,279
  • High / Low ₹ 9,380 / 5,330
  • Stock P/E 32.3
  • Book Value ₹ 441
  • Dividend Yield 2.02 %
  • ROCE 71.1 %
  • ROE 51.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
  • Company has been maintaining a healthy dividend payout of 131%

Cons

  • Stock is trading at 18.8 times its book value
  • The company has delivered a poor sales growth of 0.57% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
720 725 789 754 688 707 699 692 672 736 706 715 694
553 536 542 556 561 512 538 510 505 507 528 506 506
Operating Profit 167 189 247 199 127 194 161 182 167 230 178 208 187
OPM % 23% 26% 31% 26% 18% 28% 23% 26% 25% 31% 25% 29% 27%
24 26 17 504 16 142 16 11 34 44 16 12 12
Interest 0 0 0 0 0 0 0 0 0 0 1 0 0
Depreciation 20 20 21 14 11 11 11 10 10 10 10 10 10
Profit before tax 170 195 243 688 132 326 166 182 190 264 183 210 189
Tax % 28% 25% 26% 23% 32% 27% 27% 28% 31% 28% 33% 28% 27%
123 146 178 530 90 238 120 131 131 190 123 152 138
EPS in Rs 53.41 63.35 77.42 230.04 39.25 103.51 52.28 56.84 56.84 82.67 53.36 66.09 59.79
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
1,573 1,809 1,977 2,193 2,367 2,460 2,771 3,071 2,902 2,957 2,770 2,851
1,261 1,411 1,639 1,817 1,832 1,921 2,146 2,403 2,186 2,194 2,066 2,047
Operating Profit 312 398 339 376 535 538 625 667 716 762 704 804
OPM % 20% 22% 17% 17% 23% 22% 23% 22% 25% 26% 25% 28%
41 83 131 218 66 79 88 33 45 564 204 83
Interest 1 0 0 0 2 1 1 0 2 2 2 2
Depreciation 90 92 97 113 119 102 103 100 82 67 42 40
Profit before tax 262 388 373 481 480 515 610 600 677 1,258 864 846
Tax % 32% 32% 29% 33% 37% 37% 38% 31% 29% 25% 28% 29%
177 265 264 322 304 326 381 414 478 944 621 603
EPS in Rs 76.71 115.14 114.46 139.60 132.09 141.55 165.26 179.85 207.38 410.06 269.47 261.91
Dividend Payout % 43% 39% 39% 46% 51% 50% 51% 194% 176% 119% 211% 64%
Compounded Sales Growth
10 Years: 5%
5 Years: 1%
3 Years: -1%
TTM: 3%
Compounded Profit Growth
10 Years: 9%
5 Years: 9%
3 Years: 5%
TTM: 12%
Stock Price CAGR
10 Years: 10%
5 Years: 8%
3 Years: 3%
1 Year: 37%
Return on Equity
10 Years: 22%
5 Years: 27%
3 Years: 33%
Last Year: 52%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Equity Capital 23 23 23 23 23 23 23 23 23 23 23 23
Reserves 1,181 1,324 1,463 1,604 1,860 2,003 2,196 2,419 2,096 2,203 1,253 992
0 0 0 0 0 0 0 0 23 25 24 19
427 532 742 778 658 751 765 802 777 811 772 681
Total Liabilities 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715
699 699 648 877 817 769 733 499 464 334 306 315
CWIP 43 136 210 22 34 30 21 17 10 13 24 16
Investments 0 0 0 0 0 0 0 0 0 0 0 2
888 1,043 1,369 1,505 1,690 1,978 2,230 2,728 2,444 2,714 1,743 1,382
Total Assets 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
290 273 265 213 322 435 374 412 611 559 399 231
-5 -335 61 36 -155 -79 -73 66 276 631 651 36
-90 -105 -122 -147 -180 -188 -197 -183 -810 -849 -1,583 -878
Net Cash Flow 195 -168 205 102 -13 168 104 295 78 341 -533 -612

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023
Debtor Days 23 24 21 24 22 29 21 27 19 18 17 17
Inventory Days 135 151 179 173 169 151 154 127 107 110 125 202
Days Payable 75 83 122 81 79 119 110 100 93 105 109 89
Cash Conversion Cycle 83 92 78 115 112 61 65 54 33 22 33 130
Working Capital Days 3 43 26 9 79 17 18 35 -7 -19 -18 25
ROCE % 23% 29% 22% 26% 27% 26% 29% 28% 32% 35% 41% 71%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
10.87% 10.34% 9.22% 8.99% 8.71% 8.26% 6.99% 6.71% 6.72% 6.80% 6.31% 6.11%
17.41% 17.67% 19.05% 18.65% 18.59% 18.28% 19.22% 19.46% 19.65% 21.68% 22.51% 22.88%
11.33% 11.59% 11.33% 11.96% 12.30% 13.08% 13.41% 13.43% 13.22% 11.10% 10.78% 10.61%
No. of Shareholders 53,56751,64650,91659,27664,54273,73474,59376,69471,51368,59862,87061,849

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls